Nebius Group Stock (NBIS)

Track Nebius Group stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

At close

$221.07

▲ +1.36 (+0.62%)

Oct 9, 4:00 PM ET

After-hours

$221.33

▲ +0.26 (+0.12%)

Oct 9, 7:59 PM ET

Market Cap

$60.10B

P/E Ratio

855.0x

1Y Return

+66.67%

EPS (TTM)

$0.26

Read the latest TheStreet Pro articles mentioning Nebius Group, including market roundups, portfolio updates, trade ideas, and investing analysis.

Daily Diary Mentions

1 mention

Sep 17 · 9:10 AM ETUpside, Downside Movers in the Morning
Upside – $AEMD +403% (merger agreement with North Immunology adds an IL-13 x IL-18 bispecific-antibody program for atopic dermatitis) – $GNRC +30% (Amazon supply agreement includes $2.4B of backup-generator deliveries expected during 2027-2028) – $VEEA +30% (non-binding combination term sheet with NovaGen targets a $750M AI-health platform) – $DTSS +12% (strategic cooperation expands into AI-powered …
NBIS AEMD ANET
Read in context ›